Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP221403.RAw5FlAH7EDe5_pB4BW4VwIu-jZI_0hv15e2rGodSB1N4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP221403.RAw5FlAH7EDe5_pB4BW4VwIu-jZI_0hv15e2rGodSB1N4130_assertion type Assertion NP221403.RAw5FlAH7EDe5_pB4BW4VwIu-jZI_0hv15e2rGodSB1N4130_head.
- NP221403.RAw5FlAH7EDe5_pB4BW4VwIu-jZI_0hv15e2rGodSB1N4130_assertion description "[We have determined the prevalence of amplification and rearrangements for c-myc, c-myb, c-mos, bcr, c-abl, c-Ha-ras-1, c-N-ras, and c-K-ras-2 in a total of 51 cases of human leukaemia (19 patients with AML, 13 cases with CML, 14 cases with ALL, and 5 cases with CLL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221403.RAw5FlAH7EDe5_pB4BW4VwIu-jZI_0hv15e2rGodSB1N4130_provenance.
- NP221403.RAw5FlAH7EDe5_pB4BW4VwIu-jZI_0hv15e2rGodSB1N4130_assertion evidence source_evidence_literature NP221403.RAw5FlAH7EDe5_pB4BW4VwIu-jZI_0hv15e2rGodSB1N4130_provenance.
- NP221403.RAw5FlAH7EDe5_pB4BW4VwIu-jZI_0hv15e2rGodSB1N4130_assertion SIO_000772 2888656 NP221403.RAw5FlAH7EDe5_pB4BW4VwIu-jZI_0hv15e2rGodSB1N4130_provenance.
- NP221403.RAw5FlAH7EDe5_pB4BW4VwIu-jZI_0hv15e2rGodSB1N4130_assertion wasDerivedFrom befree-20140225 NP221403.RAw5FlAH7EDe5_pB4BW4VwIu-jZI_0hv15e2rGodSB1N4130_provenance.
- NP221403.RAw5FlAH7EDe5_pB4BW4VwIu-jZI_0hv15e2rGodSB1N4130_assertion wasGeneratedBy ECO_0000203 NP221403.RAw5FlAH7EDe5_pB4BW4VwIu-jZI_0hv15e2rGodSB1N4130_provenance.